BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks

Yan, Winston X., Mirzazadeh, Reza, Garnerone, Silvano, Scott, David, Schneider, Martin W., Kallas, Tomasz, Custodio, Joaquin, Wernersson, Erik +7 more·2017·Nature Communications
DOI 10.1038/ncomms15058

Cited by (369)

Items 101–200 of 369

  1. Methodologies for detecting environmentally induced DNA damage and repair
    Wentao Li, Aziz Sancar · 2020 · Environmental and Molecular Mutagenesis
  2. Technologies and Computational Analysis Strategies for CRISPR Applications
    Kendell Clement, Jonathan Y. Hsu, Matthew C. Canver, J. Keith Joung, Luca Pinello · 2020 · Molecular Cell
  3. Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito
    William T. Garrood, Nace Kranjc, Karl Petri, Daniel Y. Kim, Jimmy A. Guo, Andrew Hammond, Ioanna Morianou, Vikram Pattanayak, J. Keith Joung, Andrea Crisanti et al. · 2021 · Proceedings of the National Academy of Sciences
  4. TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor
    Jeonghun Kwon, Minyoung Kim, Seung-Min Bae, Anna Jo, Young-Ho Kim, Jungjoon K. Lee · 2022 · Nature Communications
  5. Genome-wide detection of DNA double-strand breaks by in-suspension BLISS
    Britta A. M. Bouwman, Federico Agostini, Silvano Garnerone, Giuseppe Petrosino, Henrike Johanna Gothe, Sergi Sayols, Andreas E. Moor, Shalev Itzkovitz, Magda Bienko, Vassilis Roukos et al. · 2020 · Nature Protocols
  6. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders
    Sudhanshu P. Raikwar, Nidhi Shankar Kikkeri, Ragha Chaitanya Sakuru, Daniyal Saeed, Haris Zahoor, Keerthivaas Premkumar, Shireen Mentor, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed et al. · 2019 · Journal of Neuroimmune Pharmacology
  7. Predicting double-strand DNA breaks using epigenome marks or DNA at kilobase resolution
    Raphaël Mourad, Krzysztof Ginalski, Gaëlle Legube, Olivier Cuvier · 2018 · Genome biology
  8. Translating CRISPR-Cas Therapeutics: Approaches and Challenges
    Lavina Sierra Tay, Nathan D. Palmer, Rebecca Panwala, Wei Leong Chew, Prashant Mali · 2020 · The CRISPR Journal
  9. Massively targeted evaluation of therapeutic CRISPR off-targets in cells
    Pan, Xiaoguang, Qu, Kunli, Yuan, Hao, Xiang, Xi, Anthon, Christian, Pashkova, Liubov, Liang, Xue, Han, Peng, Corsi, Giulia I., Xu, Fengping et al. · 2022 · Nature Communications
  10. Topoisomerase II contributes to DNA secondary structure-mediated double-stranded breaks
    Karol A. Szlachta, Arkadi Manukyan, Heather M. Raimer, Sandeep Singh, Anita Salamon, Wenying Guo, Kirill S. Lobachev, Yuh‐Hwa Wang · 2020 · Nucleic Acids Research
  11. Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects
    Karl Petri, Daniel Y. Kim, Kanae E. Sasaki, Matthew C. Canver, Xiao Wang, Hina Shah, Hyunho Lee, Joy E. Horng, Kendell Clement, Sowmya Iyer et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
    Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, Najmeh Heshmatpour, Sarita R. Patnaik · 2024 · Frontiers in Genome Editing
  13. Therapeutic genome editing in cardiovascular diseases
    Masataka Nishiga, Lei S. Qi, Joseph C. Wu · 2020 · Advanced Drug Delivery Reviews
  14. A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020
    Mai Hue Tran, HaJeung Park, Christopher L. Nobles, Pabalu P. Karunadharma, Li Pan, Guocai Zhong, Haimin Wang, Wenhui He, Tianling Ou, Gogce C. Crynen et al. · 2021 · Molecular Therapy — Nucleic Acids
  15. Negative DNA supercoiling induces genome-wide Cas9 off-target activity
    Matthew D. Newton, Marialucrezia Losito, Quentin M. Smith, Nishita Parnandi, Benjamin J. Taylor, Pınar Akçakaya, Marcello Maresca, Patrick van Eijk, Simon Huw Reed, Simon J. Boulton et al. · 2023 · Molecular Cell
  16. Identifying genome-wide off-target sites of CRISPR RNA–guided nucleases and deaminases with Digenome-seq
    Daesik Kim, Beum‐Chang Kang, Jin‐Soo Kim · 2021 · Nature Protocols
  17. A kinetic model predicts SpCas9 activity, improves off-target classification, and reveals the physical basis of targeting fidelity
    Behrouz Eslami-Mossallam, Misha Klein, Constantijn P. van der Smagt, Koen van der Sanden, Stephen K. Jones, John A. Hawkins, Ilya J. Finkelstein, Martin Depken · 2022 · Nature Communications
  18. Recent Advancements in DNA Damage–Transcription Crosstalk and High-Resolution Mapping of DNA Breaks
    Valerio Vitelli, Alessandro Galbiati, Fabio Iannelli, Fabio Pessina, Sheetal Sharma, Fabrizio d’Adda di Fagagna · 2017 · Annual Review of Genomics and Human Genetics
  19. STRIDE—a fluorescence method for direct, specific in situ detection of individual single- or double-strand DNA breaks in fixed cells
    Magdalena Kordon-Kiszala, Mirosław Zarębski, Kamil J. Solarczyk, Hanhui Ma, Thoru Pederson, Jurek W. Dobrucki · 2019 · Nucleic Acids Research
  20. Precision digital mapping of endogenous and induced genomic DNA breaks by INDUCE-seq
    Felix M. Dobbs, Patrick van Eijk, Mick D. Fellows, Luisa Loiacono, Roberto Nitsch, Simon Huw Reed · 2022 · Nature Communications
  21. Therapeutic gene editing in haematological disorders with CRISPR /Cas9
    Trine I. Jensen, Esben Axelgaard, Rasmus Otkjær Bak · 2019 · British Journal of Haematology
  22. The Secret Life of Chromosome Loops upon DNA Double-Strand Break
    Coline Arnould, Gaëlle Legube · 2019 · Journal of Molecular Biology
  23. H3K4 methylation by SETD1A/BOD1L facilitates RIF1-dependent NHEJ
    Rachel Bayley, Valérie Borel, Rhiannon J. Moss, Ellie Sweatman, Philip Ruis, Alice Ormrod, Amalia Goula, Rachel M.A. Mottram, Tyler H. Stanage, Graeme Hewitt et al. · 2022 · Molecular Cell
  24. AIRE relies on Z-DNA to flag gene targets for thymic T cell tolerization
    Yuan Fang, Kushagra Bansal, Sara Mostafavi, Christophe O. Benoist, Diane J. Mathis · 2024 · Nature
  25. Impact of Genetic Variation on CRISPR-Cas Targeting
    Matthew C. Canver, J. Keith Joung, Luca Pinello · 2018 · The CRISPR Journal
  26. Photocatalytic H2 Evolution from Ammonia Borane: Improvement of Charge Separation and Directional Charge Transmission
    Sishi Zhang, Jie Cheng Xu, Hongmei Cheng, Cuicui Zang, Fengxia Bian, Bin Sun, Yu Shen, Heyan Jiang · 2020 · ChemSusChem
  27. DNA replication initiation shapes the mutational landscape and expression of the human genome
    Pierre Murat, Consuelo Perez, Alastair Crisp, Patrick van Eijk, Simon Huw Reed, Guillaume Guilbaud, Julian E. Sale · 2022 · Science Advances
  28. Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
    Johannes Bischof, Markus Hierl, Ulrich Koller · 2024 · International Journal of Molecular Sciences
  29. Iterative crRNA design and a PAM-free strategy enabled an ultra-specific RPA-CRISPR/Cas12a detection platform
    Xujian Mao, Jian Xu, Jingyi Jiang, Qiong Li, Ping Yao, Jinyi Jiang, Li Gong, Yin Dong, Bowen Tu, Rong Wang et al. · 2024 · Communications Biology
  30. Genome-wide mapping of genomic DNA damage: methods and implications
    Amente, Stefano, Scala, Giovanni, Majello, Barbara, Azmoun, Somaiyeh, Tempest, Helen G., Premi, Sanjay, Cooke, Marcus S. · 2021 · Cellular and Molecular Life Sciences
  31. Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications
    Neena Pyzocha, Sidi Chen · 2017 · ACS Chemical Biology
  32. The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing
    Manuel M. Vicente, Miguel Chaves‐Ferreira, João M. P. Jorge, João T. Proença, Vasco M. Barreto · 2021 · Frontiers in Cell and Developmental Biology
  33. CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts
    Laura Curti, Sara Rohban, Nicola Bianchi, Ottavio Croci, Adrian Andronache, Sara Barozzi, Michela Mattioli, Fernanda Ricci, Elena Pastori, Silvia Sberna et al. · 2024 · Nature Communications
  34. Illuminating the genome-wide activity of genome editors for safe and effective therapeutics
    Yong Cheng, Shengdar Q. Tsai · 2018 · Genome biology
  35. CRISPR therapy towards an HIV cure
    Elena Herrera-Carrillo, Zongliang Gao, Ben Berkhout · 2019 · Briefings in Functional Genomics
  36. DL-CRISPR: A Deep Learning Method for Off-Target Activity Prediction in CRISPR/Cas9 With Data Augmentation
    Yu Zhang, Yahui Long, Rui Yin, Chee Keong Kwoh · 2020 · IEEE Access
  37. HIV-1 cure strategies: why CRISPR?
    Andrew Atkins, Alexander G. Allen, Will Dampier, Elias K. Haddad, Michael R. Nonnemacher, Brian L. Wigdahl · 2020 · Expert Opinion on Biological Therapy
  38. Applications of nanodosimetry in particle therapy planning and beyond
    Antoni Ruciński, Anna Biernacka, Reinhard W. Schulte · 2021 · Physics in Medicine and Biology
  39. Avoiding the off-target effects of CRISPR/cas9 system is still a challenging accomplishment for genetic transformation
    Roberto H. Herai · 2019 · Gene
  40. Harnessing noncanonical crRNA for highly efficient genome editing
    Guanhua Xun, Zhixin Zhu, Nilmani Singh, Jingxia Lu, Piyush Jain, Huimin Zhao · 2024 · Nature Communications
  41. Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
    Hongxin Huang, Yongfei Hu, Guanjie Huang, Shufeng Ma, Jianqi Feng, Dong Wang, Ying Lin, Jiajian Zhou, Zhili Rong · 2021 · Communications Biology
  42. A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell–derived allogeneic cell therapies
    Jennifer L. Dashnau, Qiong Xue, Monica Nelson, Eric Law, Lan Cao, Derek J. Hei · 2022 · Cytotherapy
  43. An Overview of Genome‐Engineering Methods
    Sushmita Sushmita, Gurminder Kaur, Santosh Kumar Upadhyay, Praveen Chandra Verma · 2021
  44. CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
    Seung Hwan Lee, Young‐Ho Park, Yeung Bae Jin, Sun‐Uk Kim, Junho K. Hur · 2019 · Trends in Molecular Medicine
  45. An Adaptive Role for DNA Double-Strand Breaks in Hippocampus-Dependent Learning and Memory
    Sydney Weber Boutros, Vivek K. Unni, Jacob Raber · 2022 · International Journal of Molecular Sciences
  46. DNA Double Strand Breaks and Chromosomal Translocations Induced by DNA Topoisomerase II
    Fernando Gómez-Herreros · 2019 · Frontiers in Molecular Biosciences
  47. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones
    Richard H. Smith, Yun-Ching Chen, Fayaz Seifuddin, Daniel N. Hupalo, Camille Alba, Robert N. Reger, Xin Tian, Daisuke Araki, Clifton L. Dalgard, Richard W. Childs et al. · 2020 · Genes
  48. Complex genomic patterns of abasic sites in mammalian DNA revealed by a high-resolution SSiNGLe-AP method
    Ye Cai, Huifen Cao, Fang Wang, Yufei Zhang, Philipp Kapranov · 2022 · Nature Communications
  49. Progress in the application of CRISPR: From gene to base editing
    Wenyi Wu, Yanhui Yang, Hetian Lei · 2018 · Medicinal Research Reviews
  50. Engineering guide RNA to reduce the off-target effects of CRISPR
    Jing Wu, Hao Yin · 2019 · Journal of genetics and genomics/Journal of Genetics and Genomics
  51. CRISPR-Cpf1 Activation of Endogenous BMP4 Gene for Osteogenic Differentiation of Umbilical-Cord-Derived Mesenchymal Stem Cells
    Jaehoon Choi, Taegeun Bae, Ninj Byambasuren, Seong-Ho Park, Chris Hyunchul Jo, Dokyoung Kim, Junho K. Hur, Nathaniel Suk-Yeon Hwang · 2020 · Molecular Therapy — Methods & Clinical Development
  52. Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
    Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Guillermo Ureña-Bailén, Janani Raju, Justin S. Antony, Rupert Handgretinger, Markus Mezger · 2019 · Blood Reviews
  53. Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
    Xiaofeng Dai, Pilar Blancafort, Peiyu Wang, Agustin Sgro, Erik W. Thompson, Kostya Ostrikov · 2020 · Advanced Science
  54. Modeling double strand break susceptibility to interrogate structural variation in cancer
    Tracy J. Ballinger, Britta A. M. Bouwman, Reza Mirzazadeh, Silvano Garnerone, Nicola Crosetto, Colin A M Semple · 2019 · Genome biology
  55. Multigene CRISPR/Cas9 genome editing of hybrid proline rich proteins (HyPRPs) for sustainable multi-stress tolerance in crops: the review of a promising approach
    Banashree Saikia, Sanjay S. Singh, Johni Debbarma, Natarajan Velmurugan, Hari Prasanna Deka Boruah, Kallare P. Arunkumar, Channakeshavaiah Chikkaputtaiah · 2020 · Physiology and Molecular Biology of Plants
  56. Genome-wide specificity of dCpf1 cytidine base editors
    Daesik Kim, Kayeong Lim, Jin‐Soo Kim, Jin‐Soo Kim · 2020 · Nature Communications
  57. PEAC-seq adopts Prime Editor to detect CRISPR off-target and DNA translocation
    Zhenxing Yu, Zhike Lu, Jingjing Li, Yingying Wang, Panfeng Wu, Yini Li, Yangfan Zhou, Bailun Li, Heng Zhang, Yingzheng Liu et al. · 2022 · Nature Communications
  58. Transformer-based anti-noise models for CRISPR-Cas9 off-target activities prediction
    Zengrui Guan, Zhenran Jiang · 2023 · Briefings in Bioinformatics
  59. Extru-seq: A method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
    Kwon, Jeonghun, Kim, Minyoung, Hwang, Woochang, Jo, Anna, Hwang, Gue-Ho, Jung, Minhee, Kim, Un Gi, Cui, Gang, Kim, Heonseok, Eom, Joon-Ho et al. · 2023 · Genome biology
  60. Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells
    Kevin Luk, Pengpeng Liu, Jing Zeng, Yetao Wang, Stacy A. Maitland, Feston Idrizi, Karthikeyan Ponnienselvan, Lihua Julie Zhu, Jeremy Luban, Daniel E. Bauer et al. · 2022 · GEN Biotechnology
  61. Modelling urea cycle disorders using iPSCs
    Claire E. Duff, Julien Baruteau · 2022 · npj Regenerative Medicine
  62. Massively parallel CRISPR off-target detection enables rapid off-target prediction model building
    Rui Tian, Chen Cao, Dan He, Dirong Dong, Lili Sun, Jiashuo Liu, Ye Chen, Yuyan Wang, Zheying Huang, Lifang Li et al. · 2023 · Med
  63. Methods and applications of genome-wide profiling of DNA damage and rare mutations
    Gerd P. Pfeifer, Seung‐Gi Jin · 2024 · Nature Reviews Genetics
  64. Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
    Kamil Moskal, Nimisha Khurana, Luisa Siegert, Ye‐Seul Lee, Hans C. Clevers, Eran Elinav, Jens Puschhof · 2024 · International Journal of Cancer
  65. Generating, modeling and evaluating a large-scale set of CRISPR/Cas9 off-target sites with bulges
    Ofir Yaish, Yaron Orenstein · 2024 · Nucleic Acids Research
  66. Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On‐ and Off‐Target Damage
    Anthony Newman, Lora M. Starrs, Gaétan Burgio · 2020 · BioEssays
  67. Gene therapy in cardiac and vascular diseases: a review of approaches to treat genetic and common cardiovascular diseases with novel gene-based therapeutics
    P. Musolino, Susan J. Rosser, M. Brittan, D. E. Newby, C. Berry, Paul R Riley, Mauro Giacca, R. Hajjar, A. Baker · 2025 · Cardiovascular Research
  68. The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness
    Célia D. Rouault, Emmanuelle Charafe‐Jauffret, Christophe Ginestier · 2025 · Nature Communications
  69. Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States
    Sara K. Oster, Rami I. Aqeilan · 2020 · Cells
  70. DROSHA is recruited to DNA damage sites by the MRN complex to promote non-homologous end joining
    Matteo Cabrini, Marco Roncador, Alessandro Galbiati, Lina Cipolla, Antonio Maffia, Fabio Iannelli, Simone Sabbioneda, Fabrizio d’Adda di Fagagna, Sofia Francia · 2021 · Journal of Cell Science
  71. RAD51-mediated R-loop formation acts to repair transcription-associated DNA breaks driving antigenic variation in Trypanosoma brucei
    Mark John Girasol, Marija Krasiļņikova, Catarina A. Marques, Jeziel D. Damasceno, Craig T. Lapsley, Leandro Lemgruber, Richard Burchmore, Dario Beraldi, Ross Carruthers, Emma M. Briggs et al. · 2023 · Proceedings of the National Academy of Sciences
  72. Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
    Lea Isabell Schwarze, Dawid Głów, Tanja Sonntag, Almut Uhde, Boris Fehse · 2021 · Gene Therapy
  73. Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA
    Polina Selkova, Aleksandra Vasileva, Georgii E. Pobegalov, Olga S. Musharova, Anatolii Arseniev, Maksim Kazalov, Tatyana Zyubko, Nataliia Shcheglova, Tatyana Artamonova, Mikhail A. Khodorkovskii et al. · 2020 · RNA Biology
  74. A graph neural network-based interpretable framework reveals a novel DNA fragility–associated chromatin structural unit
    Yu Sun, Xiang Xu, Lin Lin, Kang Xu, Yang Zheng, Chao Ren, Huan Tao, Xu Wang, Huan Zhao, Wei-Wei Tu et al. · 2023 · Genome biology
  75. A systematic evaluation of data processing and problem formulation of CRISPR off-target site prediction
    Yaish, Ofir, Asif, Maor, Orenstein, Yaron · 2022 · Briefings in Bioinformatics
  76. Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    James B. Papizan, Shaina N. Porter, Akshay Sharma, Shondra M. Pruett‐Miller · 2020 · Journal of Biomedical Research
  77. Photoluminescence‐Induced Four‐Wave Mixing Generation in a Monolayer‐MoS2‐Cladded GaN Microdisk Resonator
    Hao Chen, Kai Guo, Jinde Yin, Siqing He, Guoqing Qiu, Mengyu Zhang, Zihan Xu, Gangyi Zhu, Junbo Yang, Peiguang Yan · 2021 · Laser & Photonics Review
  78. UdgX-Mediated Uracil Sequencing at Single-Nucleotide Resolution
    Liudan Jiang, Jiayong Yin, Maoxiang Qian, Shaoqin Rong, Shengqi Zhang, Kejing Chen, Chengchen Zhao, Yuanqing Tan, Jiayin Guo, Hao Chen et al. · 2022 · Journal of the American Chemical Society
  79. Identification of Guide-Intrinsic Determinants of Cas9 Specificity
    Nicholas C. Huston, Josh Tycko, Eric L. Tillotson, Christopher J. Wilson, Vic E. Myer, Hariharan Jayaram, Barrett E. Steinberg · 2019 · The CRISPR Journal
  80. NELF complex fosters BRCA1 and RAD51 recruitment to DNA damage sites and modulates sensitivity to PARP inhibition
    Laila A. Bishara, Feras E. Machour, Samah W. Awwad, Nabieh Ayoub · 2020 · DNA repair
  81. Genome-wide detection and analysis of CRISPR-Cas off-targets
    Tomás Rodríguez, Sina Dadafarin, Henry Pratt, Pengpeng Liu, Nadia Amrani, Lihua Julie Zhu · 2021 · Progress in molecular biology and translational science
  82. Genome-Wide Profiling of DNA Double-Strand Breaks by the BLESS and BLISS Methods
    Reza Mirzazadeh, Tomasz Kallas, Magda Bienko, Nicola Crosetto · 2017 · Methods in molecular biology
  83. A novel NGS library preparation method to characterize native termini of fragmented DNA
    Kelly M. Harkins, Nathan K. Schaefer, Christopher J. Troll, Varsha Rao, Joshua D. Kapp, Colin Naughton, Beth Shapiro, Richard Edward Green · 2020 · Nucleic Acids Research
  84. DNA damage resulting from human endocrine disrupting chemical exposure: Genotoxicity, detection and dietary phytochemical intervention
    Xiaoqing Li, Ningzi Zang, Nan Zhang, Lijian Pang, Ling Lv, Xiansheng Meng, Xiaodong Lv, Jiapeng Leng · 2023 · Chemosphere
  85. CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
    Carolyn M. Yrigollen, Beverly L. Davidson · 2019 · Brain Sciences
  86. Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors
    Kshitiz Singh, Raffaele Fronza, Hanneke Evens, Marinee Chuah, Thierry VandenDriessche · 2024 · Molecular Therapy — Methods & Clinical Development
  87. O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage
    Aishwarya Gondane, Samuel Girmay, Alma Helevä, Satu Pallasaho, Massimo F. Loda, Harri M. Itkonen · 2022 · Journal of Biomedical Science
  88. Perfecting Targeting in CRISPR
    Hainan Zhang, Tong Li, Yidi Sun, Hui Yang · 2021 · Annual Review of Genetics
  89. Efficient multiplex CRISPR/Cpf1 (Cas12a) genome editing system in Aspergillus aculeatus TBRC 277
    Dede Abdulrachman S, Verawat Champreda, Lily Eurwilaichitr, Duriya Chantasingh, Kusol Pootanakit · 2022 · Journal of Biotechnology
  90. Crispr-SGRU: Prediction of CRISPR/Cas9 Off-Target Activities with Mismatches and Indels Using Stacked BiGRU
    Guishan Zhang, Ye Luo, Huanzeng Xie, Zhiming Dai · 2024 · International Journal of Molecular Sciences
  91. CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease
    Erin R. Burnight, Laura R. Bohrer, Joseph C. Giacalone, Darcey Klaahsen, Heather T. Daggett, Jade S. East, Robert A Madumba, Kristan S. Worthington, Robert F. Mullins, Edwin M. Stone et al. · 2018 · The CRISPR Journal
  92. CrisPR/CRIS systems are highly effective and useful for genomic manipulation. Despite this, cardiac treatment remains difficult due to existing genome editing and delivery processes.
    Moataz Dowaidar · 2021
  93. An atlas of endogenous DNA double-strand breaks arising during human neural cell fate determination
    Roberto Ballarino, Britta A. M. Bouwman, Federico Agostini, Luuk Harbers, Constantin Diekmann, Erik Wernersson, Magda Bienko, Nicola Crosetto · 2022 · Scientific Data
  94. Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
    Neil T. Sullivan, Alexander G. Allen, Andrew Atkins, Cheng-Han Chung, Will Dampier, Michael R. Nonnemacher, Brian L. Wigdahl · 2020 · Frontiers in Microbiology
  95. AAV-mediated in vivo genome editing in vascular endothelial cells
    Wenyi Wu, Yanhui Yang, Fei Yao, Lijun Dong, Xiaobo Xia, Shaochong Zhang, Hetian Lei · 2020 · Methods
  96. DNA Damage Atlas: an atlas of DNA damage and repair
    Liang Yu, Qingqing Yuan, Qijie Zheng, Zilv Mei, Yawei Song, Huan Yan, Jiajie Yang, Shuheng Wu, Jiao Yuan, Wei Wu · 2023 · Nucleic Acids Research
  97. Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
    Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler · 2024 · International Journal of Molecular Sciences
  98. Exploring the SSBreakome: genome‐wide mapping of DNA single‐strand breaks by next‐generation sequencing
    Nicola Zilio, Helle D. Ulrich · 2020 · FEBS Journal
  99. Emerging Technologies for Genome-Wide Profiling of DNA Breakage
    Matthew J. Rybin, Melina Ramic, Natalie R. Ricciardi, Philipp Kapranov, Claes Wahlestedt, Zane R. Zeier · 2021 · Frontiers in Genetics
  100. Gene editing & stem cells
    Patrick T. Harrison, Nils Hoppe, Ulrich Martin · 2017 · Journal of Cystic Fibrosis